(Q36706422)

15 August 2017

1 reference

title

Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma (English)

1 reference

15 August 2017

1 reference

human papilloma virus

1 reference

human papillomavirus

29 September 2024

Donna Dehn

1

1 reference

15 August 2017

Kathleen C Torkko

series ordinal

2

1 reference

15 August 2017

Kenneth R Shroyer

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

111

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

1-14

1 reference

Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

Do qualifiers of ASCUS distinguish between low- and high-risk patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

Variation in the incidence of AGUS between different patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

Number of cervical biopsies and sensitivity of colposcopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

Immunocytochemical detection of p16INK4a protein in scraped cervical cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Detection and genotyping of human papillomavirus in cervical samples from Italian patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Genital Human Papillomavirus Infection in Female University Students as Determined by a PCR-Based Method

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

HPV typing and testing in gynaecological pathology: has the time come?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

The molecular biology of cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Papillomaviruses in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

The papillomavirus life cycle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Human papillomavirus infection: biology, epidemiology, and prevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Molecular profiling of cervical neoplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Subclassifying atypical squamous cells in Thin-Prep cervical cytology correlates with detection of high-risk human papillomavirus DNA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

The "Inconclusive--possible high grade epithelial abnormality" category in Papanicolaou smear reporting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Evaluation of the 5-year review of negative cervical smears in patients with high grade squamous intraepithelial lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Cytopathology of false negatives preceding cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Advanced squamous cell carcinoma of the cervix with recent normal Papanicolaou tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Negative cytology preceding cervical cancer: causes and prevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

False negative rate in cervical cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Testing for human papillomavirus: data driven implications for cervical neoplasia management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Stability of archived liquid-based cervical cytologic specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Current methods of testing for human papillomavirus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Molecular detection and genotyping of human papillomavirus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

HPV testing in cervical screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

DNA microarray format for detection and subtyping of human papillomavirus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions☆

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMAP system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Bead-based multiplex genotyping of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Evaluation of the invader assay for genotyping hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Adaptation of an Invader assay for the detection of African swine fever virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

APTIMA transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.22425

1 reference

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Interactions of the human papillomavirus E7 protein with cell cycle regulators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Hand-genital transmission of genital warts? An analysis of prevalence data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Heritability of cervical tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

P16 as a molecular biomarker of cervical adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Differential expression of cdk inhibitors p16, p21cip1, p27kip1, and cyclin E in cervical cytological smears prepared by the ThinPrep method

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Expression of p16INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

p16INK4A expression in cervical premalignant and malignant lesions.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22425

7 January 2021

Identifiers

DOI

10.1002/CNCR.22425

1 reference

15 August 2017

1 reference